Lexicon Pharmaceuticals
LXRX
#6646
Rank
โ‚น77.99 B
Marketcap
โ‚น175.18
Share price
0.54%
Change (1 day)
26.94%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2026 (TTM): -โ‚น5.65 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น41.46 Million. In 2025 the company made an earning of -โ‚น4.72 Billion, an increase over its 2024 earnings that were of -โ‚น18.78 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น5.65 Billion19.64%
2025 -โ‚น4.72 Billion-74.88%
2024 -โ‚น18.78 Billion13.15%
2023 -โ‚น16.6 Billion73.74%
2022 -โ‚น9.56 Billion16.16%
2021 -โ‚น8.23 Billion49.82%
2020 -โ‚น5.49 Billion-147.19%
2019 โ‚น11.62 B-203.42%
2018 -โ‚น11.25 Billion-15.31%
2017 -โ‚น13.28 Billion0.2%
2016 -โ‚น13.25 Billion2920.7%
2015 -โ‚น0.44 Billion-95.33%
2014 -โ‚น9.41 Billion-3.61%
2013 -โ‚น9.76 Billion-5.52%
2012 -โ‚น10.33 Billion-4.17%
2011 -โ‚น10.78 Billion15.5%
2010 -โ‚น9.33 Billion8.36%
2009 -โ‚น8.61 Billion-4.81%
2008 -โ‚น9.05 Billion28.79%
2007 -โ‚น7.03 Billion35.71%
2006 -โ‚น5.18 Billion52.91%
2005 -โ‚น3.39 Billion-23.89%
2004 -โ‚น4.45 Billion-24.19%
2003 -โ‚น5.87 Billion-0.48%
2002 -โ‚น5.9 Billion44.12%
2001 -โ‚น4.09 Billion23.01%
2000 -โ‚น3.33 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น739.97 B-13,024.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น104.64 B-1,927.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น532.73 B-9,404.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚น41.9 Billion 631.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น5.70 B-199.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚น7.43 B-229.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น2.18 Billion-61.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น4.09 B-171.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น1.55 Billion-72.97%๐Ÿ‡บ๐Ÿ‡ธ USA